New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 16, 2014
11:28 EDTTMO, SVU, QEP, NAO, GLPI, ATLS, KKR, SD, C, ACTLeon Cooperman gives 12 stock picks at CNBC conference
Leon Cooperman of Omega Advisors gave 12 stock picks for 2014 at CNBC's Delivering Alpha conference. The recommendations are: Actavis (ACT), Citigroup (C), SandRidge Energy (SD), KKR (KKR), Thermo Fisher (TMO), Atlas Energy (ATLS), Gaming and Leisure Properties (GLPI), Nordic American Offshore (NAO), QEP Resources (QEP), SuperValu (SVU), Louis XIII Holdings and Monitise.
News For ACT;C;SD;KKR;ATLS;GLPI;NAO;QEP;SVU;TMO From The Last 14 Days
Check below for free stories on ACT;C;SD;KKR;ATLS;GLPI;NAO;QEP;SVU;TMO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
August 25, 2014
06:19 EDTSVUU.S. DHS warns of 'Backoff' malware, WSJ reports
The Department of Homeland Security is urging all companies to check for a "Backoff" malware infection, which targets cash registers, and said over 1,000 businesses in the U.S. have been affected by the cyberattack, the Wall Street Journal reports. The DHS said Friday that the malware has likely infected many victims who "aren't aware" that they have been compromised. Reference Link
August 24, 2014
21:23 EDTKKRLender group set to offer EDMC revised debt package, NY Post says
Subscribe for More Information
August 22, 2014
16:11 EDTACTActavis confirms generic Neupro patent challenge
Subscribe for More Information
09:36 EDTCActive equity options trading on open
Subscribe for More Information
06:12 EDTCCitigroup faces restrictions on hedge-fund sales, WSJ reports
Subscribe for More Information
August 21, 2014
15:16 EDTACTDEA restricts painkiller drug prescriptions to curb abuse, WSJ reports
The Drug Enforcement Agency, or DEA, will reclassify hydrocodone combination painkiller drugs and place them in the category of medical substances that have the highest potential for harm in an attempt to curb the widespread abuse of the drugs, according to The Wall Street Journal. The rescheduling of the drugs will take effect in 45 days and result in people being able to obtain the drug for only 90 days without obtaining a new prescription. Major manufacturers of these drugs include Teva Pharmaceutical (TEVA), Mallinckrodt (MNK), AbbVie (ABBV), and Actavis (ACT). Reference Link
10:02 EDTCActive calls at CBOE; AAPL C HPQ
Active calls at CBOE; AAPL 8/22/14 100 & 100, C Jan 55, HPQ 8/29/14 36
07:55 EDTACTActavis volatility expected to move on Pfizer considering new target report
Actavis (ACT) volatility is expected to move on Pfizer (PFE) considering other overseas alternatives, Bloomberg reports. Overall option implied volatility of 27 is near its 26-week average of 31 according to Track Data, suggesting decreasing price movement.
07:47 EDTACTPfizer looking at new targets, including Actavis, Bloomberg reports
While it weighs another attempt to acquire AstraZeneca (AZN), Pfizer is considering other overseas alternatives, including Actavis (ACT), Bloomberg reports, citing people familiar with the matter. Pfizer prefers to reach a deal with AstraZeneca, and a move on another company is unlikely "anytime soon," Bloomberg adds, citing its sources. Shares of Actavis are rising 3%, or $6.65, to $230.01 in pre-market trading, while AstraZeneca is up 2% to $72.59. Reference Link
07:38 EDTACTSupernus announces paragraph IV Abbreviated NDA filing for Trokendi XR
Subscribe for More Information
06:43 EDTCRegulators up bank warning efforts for poor risk assessment, Reuters says
Subscribe for More Information
August 20, 2014
11:44 EDTKKRMylan completes second bidding round for GSK prescription portfolio, WSJ says
Mylan (MYL), TPG Capital, Advent International, KKR (KKR), Warburg Pincus and a few Indian prescription manufacturers have completed the second round of bidding for GlaxoSmith Kline's (GSK) portfolio of mature medications, according to The Wall Street Journal, citing people familiar with the sales process. GSK noted that it aims to sell a portfolio of drug brands in the U.S. and EU with yearly sales of approximately $1.66B. Reference Link
09:22 EDTSDSandRidge Energy says COO resigns to take CEO position at another company
Subscribe for More Information
06:17 EDTCCitigroup looks to sell Japanese retail banking unit, Reuters says
Subscribe for More Information
August 19, 2014
13:08 EDTCCitigroup tells appeals court Agentina banking license at risk, Reuters reports
Subscribe for More Information
12:14 EDTCCitigroup considers selling Japan retail-banking unit, WSJ reports
Subscribe for More Information
11:18 EDTACTDepomed announces favorable ruling in Gralise case
Subscribe for More Information
10:39 EDTKKRKKR hires Rothschild for sale of Northgate's public sector unit, Reuters says
KKR has engaged Rothschild to arrange for the sale of the public sector division of its software firm Northgate Information Solutions which may fetch around $600M, says Reuters. Reference Link
10:32 EDTACTDepomed higher after favorable ruling in Gralise case
Subscribe for More Information
07:26 EDTACTActavis confirms positive results from RECLAIM pivotal Phase III studies
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use